Although CD1d expression varies among tumor types, in B cell chronic lymphocytic leukemia (CLL), the most common hematologic malignancy, the expression of CD1d is lower than that in normal B cells or is absent [41], which might allow the tumor to escape from iNKT-mediated surveillance. The gene discussed is CD1D; the disease is B-cell chronic lymphocytic leukemia.